VA Would Be Required To Study Medical Marijuana’s Benefits For Veterans With PTSD And Pain Under New Congressional Bill
Bipartisan congressional lawmakers introduced a bill to direct the U.S. Department of Veterans Affairs (VA) to carry out studies on the therapeutic potential of marijuana for military veterans with certain conditions. An earlier Senate version of the VA medical cannabis legislation cleared a committee in that chamber and was taken up on the floor for […]
Cannabis Would Be Considered A ‘High-Risk’ Product With Additional Advertising Restrictions Under New Congressional Bill
A bipartisan pair of congressional lawmakers filed a new bill aimed at protecting consumers from online scams that includes a provision designating cannabis as a “high-risk” product that would require companies advertising it to undergo enhanced verification procedures. The Stopping Abuse and Fraud Enabled by Platforms Act, or the SAFE Platforms Act, introduced last week […]
New Congressional Bill Could Boost Development Of Plant-Based Medicines, Including Those Derived From Cannabis Or Psychedelics
“The purpose is to turn up the heat and get resources to develop these more natural options that could be very important.” By Jack Gorsline, Psychedelic State(s) of America As cannabis rescheduling efforts under the Trump administration draw closer to finalization and Food and Drug Administration (FDA) approval of the first wave of synthetic psychedelic […]
Marijuana Is A ‘Gateway Drug,’ GOP Congressional Majority Leader Says As Trump Moves To Ease Federal Restrictions
One of the top Republicans in Congress says he is concerned that marijuana causes people to use other, more dangerous substances as the Trump administration is moving forward with a proposal to federally reschedule cannabis. House Majority Leader Steve Scalise (R-LA) told Marijuana Moment last week that he thinks “marijuana is a gateway drug, and […]
Congressional Researchers Call Out FDA For Not Publishing Hemp Cannabinoid Lists And Guidance On Product Containers That’s Six Months Overdue
Congressional researchers are again noting that the Food and Drug Administration (FDA) has missed a legal deadline to publish a list of known cannabinoids and guidance on hemp product containers as federal laws for the crop and its derivatives are set to change later this year in a way that stakeholders argue will upend the existing […]